When to Start Antiretroviral Therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Link
http://www.springerlink.com/index/pdf/10.1007/s11904-010-0044-6
Reference55 articles.
1. Wilkin TJ, Gulick RM: When to start antiretroviral therapy? Clin Infect Dis 2008, 47:1580–1586.
2. Volberding PA, Lagakos SW, Koch MA, et al.: Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N Engl J Med 1990, 322:941–949.
3. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee. Lancet 1994, 343:871–881.
4. Volberding PA, Lagakos SW, Grimes JM, et al.: A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group. N Engl J Med 1995, 333:401–407.
5. Ho DD: Time to hit HIV, early and hard. N Engl J Med 1995, 333:450–451.
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Persistence and risk factors of occult hepatitis B virus infections among antiretroviral therapy-naïve people living with HIV in Botswana;Frontiers in Microbiology;2024-05-09
2. Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana;Medicine;2020-02
3. Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?;Frontiers in Microbiology;2020-01-31
4. Client perspectives on an outreach approach for HIV prevention targeting Indonesian MSM and transwomen;Health Promotion International;2019-08-26
5. Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors;Molecules;2019-05-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3